Cambridge Investment Research Advisors, Inc. Tilray Brands, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Tilray Brands, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 138,555 shares of TLRY stock, worth $174,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
138,555
Previous 145,706
4.91%
Holding current value
$174,579
Previous $242,000
0.83%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding TLRY
# of Institutions
405Shares Held
99.8MCall Options Held
8.6MPut Options Held
8.9M-
Morgan Stanley New York, NY10MShares$12.6 Million0.0% of portfolio
-
Toroso Investments, LLC Massapequa, NY9.71MShares$12.2 Million0.2% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA7.65MShares$9.64 Million0.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ7.6MShares$9.57 Million0.69% of portfolio
-
Highbridge Capital Management LLC New York, NY5.19MShares$6.54 Million2.73% of portfolio
About Tilray Brands, Inc.
- Ticker TLRY
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 611,401,984
- Market Cap $770M
- Description
- Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...